<DOC>
	<DOCNO>NCT02072993</DOCNO>
	<brief_summary>This first time human study ass safety tolerability AZD1979 follow oral administration single ascend dos healthy male volunteer . Pharmacokinetics ( body drug ) parameter also assess secondary objective .</brief_summary>
	<brief_title>A First Time Man Study Assess Safety , Tolerability Pharmacokinetics AZD1979 Healthy Males</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Provision sign date , write informed consent prior study specific procedure Healthy male volunteer age 18 50 year Have BMI 18 30 kg/m2 , inclusive , weigh least 50 kg 100 kg , inclusive History clinically important disease disorder , opinion Investigator , may either put volunteer risk participation study , influence result volunteer 's ability participate study History presence gastrointestinal , hepatic , renal disease condition know interfere absorption , distribution , metabolism , excretion drug Any clinically important illness , medical/surgical procedure , trauma within 4 week first administration IP Any clinically important abnormality clinical chemistry , endocrine hormone , hematology , urinalysis result judge Investigator</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Phase I , healthy , pharmacokinetics</keyword>
</DOC>